טוען...
Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
To examine pharmacologic and clinical characteristics of neurokinin 1 (NK(1))-receptor antagonists (RAs) for preventing chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy, a literature search was performed for clinical studies in patients at risk o...
שמור ב:
| הוצא לאור ב: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178341/ https://ncbi.nlm.nih.gov/pubmed/30323622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S158570 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|